Cellular-level tissue remodelling using bioactive compounds—where medical expertise in tissue dynamics, not product marketing, determines regenerative outcomes.
Professor MacKenzie approaches tissue regeneration with surgical understanding of wound healing, collagen architecture, and cellular response mechanisms—knowledge gained from decades observing how human tissue repairs, remodels, and regenerates.
Regenerative therapies represent a fundamental shift from surface correction to biological optimisation:
Profhilo® and Skinvive — Ultra-pure hyaluronic acid that triggers fibroblast activity and neocollagenesis through bio-remodelling, not volumisation.
HarmonyCa® - this is a filler which also triggers an increase in collagen.
Polynucleotides — DNA fragments that stimulate cellular repair, enhance tissue oxygenation, and activate regenerative pathways at the molecular level.
These are not fillers. They are biological signal molecules that activate your tissue's own regenerative capacity.
All can be combined with energy-based device treatments for greater effect and maintenance of results.
Most aesthetic practitioners view these products as "skin boosters"—substances that improve appearance. Professor MacKenzie understands them as regenerative medicine—compounds that modify tissue behaviour at the cellular level.
Healing dynamics — Recognising how fibroblasts respond to bio-stimulation, how collagen remodels over time, how tissue quality affects treatment response.
Anatomical precision — Placing regenerative compounds in tissue layers where they trigger maximum biological effect—understanding dermis depth, subcutaneous planes, and vascular distribution.
Integration planning — Combining regenerative therapies with aesthetic treatments and longevity protocols for compounded outcomes. The healthier you are, the more healthy collagen and elastic you can create in response to regenerative techniques.
Cellular health evaluation — Testing markers that indicate regenerative capacity, oxidative stress, and tissue ageing.
Hormonal optimisation — Addressing imbalances (oestrogen, thyroid) that affect collagen production and skin quality.
Nutritional support — Ensuring amino acid availability, micronutrient status, and metabolic factors that drive tissue repair.
WHAT TO EXPECT
Comprehensive tissue evaluation including skin quality analysis, assessment of collagen density, identification of areas requiring regeneration.
CONSULTATION
Precision injection using cannula or needle based on tissue planes. 1-3 sessions 2-4 weeks apart.
Technique
Topical anaesthesia, brief procedure time.
COMFORT
Minimal—temporary injection site marks, possible mild swelling for 24-48 hours, occasional bruising
DOWNTIME
Immediate: Hydration improvement (Skinvive® and Profhilo®)
2-4 weeks: Initial regenerative changes visible
4-8 weeks: Significant tissue quality improvement.
3-6 months: Progressive enhancement as collagen remodelling continues.
Maintenance: Designed as part of ongoing longevity strategy, not isolated cosmetic treatments.
RESULTS
Stage 1
Redness appears occasionally and is often triggered by hot drinks, spicy food, or exercise.
Stage 2
Redness becomes more consistent. Small visible blood vessels (telangiectasia) may appear.
Stage 3
Acne-like breakouts begin, without blackheads. Skin may feel sore or sensitive.
Stage 4
Skin may thicken, particularly around the nose (rhinophyma).
Stage 5
In rare cases, severe rosacea - called phymatous rosacea - can lead to the development of rhinophyma - a bulbous enlargement of the nose, most common in men. Rosacea can also be ocular when it is located on the eyelids, conjunctiva and cornea, manifesting itself as red, watery and very dry eyes.
Diferentes etapas de la rosácea:
